U.S. Water Utilities Stock News

NasdaqGM:LMAT
NasdaqGM:LMATMedical Equipment

LeMaitre Vascular (LMAT) Valuation Check After Mixed Share Performance And Growth Trends

With no single headline event driving LeMaitre Vascular (LMAT) today, the story for investors centers on how its recent share performance and underlying financial profile line up with expectations. See our latest analysis for LeMaitre Vascular. At a share price of $85.80, LeMaitre Vascular has paired a 7.02% year to date share price return with an 88.03% three year total shareholder return, while the 1 year total shareholder return of a 13.10% decline suggests some of that earlier momentum...
NYSE:AMRC
NYSE:AMRCConstruction

How Ameresco’s Nuclear Micro Reactor Partnership (AMRC) Has Changed Its Investment Story

NANO Nuclear Energy Inc. announced that it had signed a Memorandum of Understanding with Ameresco to explore integrating advanced modular micro reactors, including the KRONOS MMR™ energy system, with Ameresco's engineering, procurement, and construction capabilities for potential deployment on federal and commercial sites. This collaboration framework positions Ameresco to apply its project delivery expertise to early-stage nuclear micro reactor concepts across siting, development,...
NYSE:IMAX
NYSE:IMAXEntertainment

IMAX (IMAX) Valuation Check After Exclusive Dune Part Three IMAX Run Announcement

IMAX’s exclusive Dune Part Three run puts premium screens in focus IMAX (IMAX) is back in the spotlight after Warner Bros. confirmed Dune Part Three will occupy all IMAX screens for three weeks from December 18, 2026, concentrating premium box office demand on the format. See our latest analysis for IMAX. The Dune Part Three announcement lands after a strong run in IMAX’s shares, with a 7 day share price return of 9.14% and a 90 day share price return of 17.31%, while the 1 year total...
NasdaqGS:TTAN
NasdaqGS:TTANSoftware

ServiceTitan (TTAN) Is Down 11.7% After Launching End-to-End AI Automation For Enterprise Contractors – Has The Bull Case Changed?

In January 2026, ServiceTitan announced that Southern Home Services became the first enterprise-size business to adopt its Max Program, integrating native AI across demand generation, dispatching, and job execution. A few days earlier, ServiceTitan also introduced AI-driven Accounts Payable Automation, Tap to Pay mobile payments, and integrated financing, deepening its role as an all-in-one fintech and operations platform for contractors. We’ll now examine how end-to-end AI automation for...
NasdaqGS:CEG
NasdaqGS:CEGElectric Utilities

Why Constellation Energy (CEG) Is Down 11.4% After PJM Price Caps and Auction Reforms - And What's Next

The Trump administration, working with Mid-Atlantic governors, recently moved to impose price caps and push emergency auctions in the PJM power grid, raising questions about how Constellation Energy can monetize its large nuclear and gas generation portfolio in that region. An underappreciated angle is that while the policy may restrict pricing on existing plants, it could also channel long-term contracts toward new Constellation-backed capacity builds. We’ll now examine how these new PJM...
NYSE:NRG
NYSE:NRGElectric Utilities

The Bull Case For NRG Energy (NRG) Could Change Following Planned CEO And Board Chair Succession

NRG Energy has outlined a planned leadership transition in which long-time executive Robert J. Gaudette became President on January 7, 2026 and is set to assume the CEO role on April 30, 2026, while current Chair and CEO Lawrence Coben will shift to an advisory position for the remainder of the year. The succession plan also reshapes board leadership, with Lead Independent Director Antonio Carrillo scheduled to become Chair on April 30, 2026, signaling a broader governance reset alongside...
NasdaqGS:ROST
NasdaqGS:ROSTSpecialty Retail

Ross Stores Balances Same Store Sales Strength With Aggressive Expansion

Ross Stores (NasdaqGS:ROST) is reporting strong same store sales growth, reflecting solid demand for its off price offering. The company has completed a CEO transition while maintaining operational momentum. Management is continuing with an aggressive store expansion program across its footprint. Ross Stores, trading at $189.69, has seen its shares rise 28.8% over the past year and 79.6% over the past five years. Over the past three years, the stock is up 66.5%, while year to date it is up...
NasdaqGS:TXRH
NasdaqGS:TXRHHospitality

Texas Roadhouse Margins Improve As Stable Traffic Supports Earnings Outlook

Texas Roadhouse (NasdaqGS:TXRH) is seeing improving gross margins, supported by stable customer traffic and favorable commodity dynamics. Recent cuts to tariffs on Brazilian beef are expected to ease input costs for the company. Consistent customer traffic and rising same-store sales continue to stand out against broader industry concerns about wage and commodity inflation. Texas Roadhouse, the casual dining steakhouse chain, sits at the center of several important shifts in the restaurant...
NYSE:UNFI
NYSE:UNFIConsumer Retailing

Securities Class Action Progress Could Be A Game Changer For United Natural Foods (UNFI)

Kahn Swick & Foti, LLC recently continued its investigation into United Natural Foods after a court allowed a securities class action lawsuit, tied to earlier disclosures of profit and net income declines, to move forward. This procedural step keeps legal and fiduciary conduct questions around United Natural Foods’ leadership in focus, adding complexity to the company’s risk profile. Against this backdrop, we’ll examine how the ongoing securities class action and related fiduciary concerns...
NasdaqGS:ORLY
NasdaqGS:ORLYSpecialty Retail

Is It Too Late To Reassess O'Reilly Automotive (ORLY) After Strong Multi‑Year Returns?

If you are wondering whether O'Reilly Automotive's share price still stacks up to its fundamentals, this article will walk you through what the current market price could be implying about value. The stock has returned 0.6% over the last 7 days, 4.7% over the past month, 5.4% year to date and 15.1% over the last year, with a 3 year return of 78.8% and a 5 year return of 214.3% that many investors will be paying close attention to when thinking about upside and risk. Recent coverage around...
NYSE:HG
NYSE:HGInsurance

Assessing Hamilton Insurance Group (HG) Valuation As Earnings And Sales Headwinds Raise Investor Concerns

Recent concerns around Hamilton Insurance Group (HG) Recent commentary around Hamilton Insurance Group (HG) has focused on a projected 2% sales decline, reduced operational productivity, and a significant contraction in earnings per share, which together appear to be weighing on investor sentiment. See our latest analysis for Hamilton Insurance Group. Hamilton Insurance Group’s recent share price moves tell a mixed story, with a 10.29% 90 day share price return and 36.20% 1 year total...
NYSE:RGA
NYSE:RGAInsurance

Is Reinsurance Group of America (RGA) Pricing Look Attractive After Recent Share Price Weakness

If you are wondering whether Reinsurance Group of America (RGA) is priced attractively right now, the key question is how its current share price compares with its underlying value. The stock last closed at US$194.33, with a 1.8% decline over the past week, a 5.5% decline over the past month, a 4.5% decline year to date, and a 42.1% return over three years and 100.3% over five years. Recent price moves come against a backdrop of ongoing sector-wide focus on life and health reinsurance, where...
NasdaqGM:KOD
NasdaqGM:KODBiotechs

Kodiak Sciences (KOD) Valuation Check As Phase 3 Readouts And Capital Raise Focus Investor Attention

Event driven setup for Kodiak Sciences Kodiak Sciences (KOD) has just finished enrolling patients in its Phase 3 diabetic retinopathy trial, with topline data expected in Q1 2026 and additional wet AMD results targeted for Q2 2026. Those timelines, together with a recent capital raise to support operations through these readouts, are now central to how investors are evaluating Kodiak’s risk profile and potential reward. See our latest analysis for Kodiak Sciences. After a sharp run over the...
NasdaqGS:GLUE
NasdaqGS:GLUEBiotechs

A Look At Monte Rosa Therapeutics (GLUE) Valuation After Positive MRT-8102 Phase 1 Interim Data

Monte Rosa Therapeutics (GLUE) just reported positive interim Phase 1 data for MRT-8102, with strong target engagement, reductions in hsCRP and IL-6, and a favorable safety profile that appears to have caught investors' attention. See our latest analysis for Monte Rosa Therapeutics. The positive MRT-8102 update lands after a very strong run in the shares, with a 30-day share price return of 57.27% and a 90-day share price return of 161.39%. The 1-year total shareholder return is extremely...
NasdaqGS:METC
NasdaqGS:METCMetals and Mining

Jefferies Upgrade Puts Ramaco’s Coal And Rare Earth Story In Focus

Jefferies has upgraded Ramaco Resources (NasdaqGS:METC) from Hold to Buy. The upgrade is linked to potential upside in metallurgical coal prices. Jefferies also points to positive sentiment around Ramaco's Brook Mine rare earth project. Geopolitical developments are a key part of the thesis behind the new rating. Ramaco Resources is a producer of metallurgical coal used primarily in steelmaking. Any shift in coal pricing can quickly change how investors view the stock. The new rating from...
NYSE:WMB
NYSE:WMBOil and Gas

Is Williams Companies (WMB) Pricing Make Sense After Strong Five Year Share Gains?

If you are looking at Williams Companies and wondering whether the current price really reflects its value, you are not alone. The stock last closed at US$61.51, with returns of 1.7% over the past week, 5.6% over the past month, 1.1% year to date, 5.0% over the past year and a very large gain over five years, with the 5-year return roughly 3x the 3-year return of 123.5%. Recent coverage around Williams Companies has focused on its role in the broader energy infrastructure space and how that...
NYSE:ARW
NYSE:ARWElectronic

Arrow Electronics Taps AI Glasses Partnership To Deepen Design Services Role

Arrow Electronics (NYSE:ARW) announced a new partnership with Romanian startup .lumen to scale manufacturing of AI-powered glasses for the blind. The collaboration focuses on sourcing components, engineering support, and product optimization to help bring the assistive device to a broader user base. The announcement highlights Arrow’s role in socially focused hardware projects that apply advanced AI to real world accessibility challenges. Arrow Electronics, trading at $113.37, is working...
NasdaqGS:HIMX
NasdaqGS:HIMXSemiconductor

Himax Technologies (HIMX) Valuation Check After New AR Glasses Reference Design With Vuzix

Himax Technologies (HIMX) is back in focus after unveiling a new optical component reference design for augmented reality glasses with Vuzix. The design pairs its HX7319FL LCoS microdisplay with Vuzix waveguide technology. See our latest analysis for Himax Technologies. The new AR reference design is landing after a softer patch for Himax, with the share price at US$8.17 and a 1 year total shareholder return of 11.15% decline. The 3 year total shareholder return of 22.60% points to longer...
NasdaqGS:SEDG
NasdaqGS:SEDGSemiconductor

SolarEdge Faces Debt And Profitability Strain As Shipment Declines Deepen

SolarEdge Technologies is facing ongoing operational and financial pressures, including sustained shipment declines and weak demand over the past two years. The company is dealing with deteriorating return on invested capital alongside negative EBITDA and a high debt load. These combined issues are raising fresh concerns about the company’s ability to sustain current operations and its longer term outlook for investors in NasdaqGS:SEDG. SolarEdge Technologies, trading on NasdaqGS:SEDG at...
NYSE:CI
NYSE:CIHealthcare

Is Cigna Group (CI) Pricing Look Anomaly After Mixed Returns And DCF Signal?

If you are wondering whether Cigna Group's current share price reflects its true worth, you are not alone. This article focuses on what the underlying numbers may suggest about value. Cigna Group recently closed at US$271.24, with returns of a 0.2% decline over the past week and 30 days, a 2.8% decline year to date, a 4.1% decline over one year, but a 37.4% gain over five years. Recent coverage has focused on Cigna's position as a major U.S. health insurer and pharmacy benefits manager, as...
NYSE:DBD
NYSE:DBDTech

Is Diebold Nixdorf (DBD) Still Attractively Priced After Its Strong 1-Year Rally?

If you are wondering whether Diebold Nixdorf at around US$68.61 is still offering value after its recent run, you are not alone. The stock is roughly flat over the last month at 0.1%, but still up 7.3% year to date and 49.5% over the past year. This can change how the market is pricing its risks and opportunities. Recent coverage has focused on the company as an established player in banking and retail technology, with attention on its efforts to stabilise operations and simplify its...
NasdaqGS:MDLZ
NasdaqGS:MDLZFood

Mondelez Canada Launches Test How Experiential Snacking Supports MDLZ Growth

Mondelez International (NasdaqGS:MDLZ) has introduced OREO Cakesters Double Chocolate and RITZ Drizzled Minis to the Canadian market. The launches are supported by the OREO Cakesters Soft Factory immersive experience at Toronto Eaton Centre. RITZ Drizzled Minis are being promoted through a partnership with Canadian siblings Johnny and Lauren Orlando, including a RITZ branded Spotify playlist. For investors watching NasdaqGS:MDLZ, these Canada focused launches show how the company is using...
NYSE:CNP
NYSE:CNPIntegrated Utilities

A Look At CenterPoint Energy (CNP) Valuation As Optimism Builds Around Q4 2025 Outlook

Analysts’ optimism sets the stage for CenterPoint’s next earnings update Investor attention on CenterPoint Energy (CNP) has picked up as Wall Street anticipates robust Q4 2025 results, following strong recent earnings and reaffirmed higher guidance for 2025 and 2026. That shift in sentiment is also tied to accelerating grid investment, clearer visibility on future rate recovery, and a focus on financial discipline. All of these factors are feeding into renewed interest in the stock. See our...
NasdaqGS:TLRY
NasdaqGS:TLRYPharmaceuticals

Is Tilray Brands (TLRY) Now A Value Opportunity After Recent Share Price Weakness?

If you are wondering whether Tilray Brands shares are cheap, expensive, or somewhere in between, you are in the right place for a clear look at what the current price might actually represent. The stock last closed at US$8.75, with returns of a 6.8% decline over 7 days, a 21.6% decline over 30 days, a 10.0% decline year to date, and a 25.2% decline over the past year, which may signal that the market is reassessing both its potential and its risks. Recent news around Tilray Brands has...